Valuation: BioNTech SE

Market Cap 20.25B 23.04B 18.85B 17.31B 32.51B 2,209B 32.94B 224B 87.51B 1,091B 86.47B 84.61B 3,770B P/E 2026 *
-18.2x
P/E 2027 * -17.5x
Enterprise Value 9.4B 10.69B 8.75B 8.03B 15.08B 1,025B 15.28B 104B 40.6B 506B 40.12B 39.26B 1,749B EV / Sales 2026 *
4.33x
EV / Sales 2027 * 4.92x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day+1.97%
1 week-1.16%
Current month-2.11%
1 month-0.14%
3 months-10.75%
6 months-23.67%
Current year-4.32%
1 week 88.5
Extreme 88.5
93.15
1 month 88.35
Extreme 88.35
98.81
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
464
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 60 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 55 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap.
12/5/26 Free

Chief Operating Officer

22,655 0.0094%
12/5/26 Free

Chief Financial Officer

33,982 0.0141%
12/5/26 Free

Head of Human Resources

18,879 0.0078%
Change 5-day change 1-year change 3-year change Capi.($)
+1.97%-1.16%-21.00%-13.25% 23.04B
-0.72%+3.12%+53.17%+72.67% 56.19B
-0.27%+0.35%+40.26%+79.88% 54.83B
-2.05%-2.14%+0.75%+413.38% 22.7B
-0.83%-1.24%+19.81%-11.45% 20.23B
-1.49%+1.27%+25.28%-30.70% 17.83B
-2.04%-1.76%+31.54%+542.99% 15.65B
+5.29%+1.70%+185.09%+333.94% 15.24B
+0.79%+0.50%+22.39%+184.74% 14.03B
+1.24%+2.90%+84.74%+175.74% 12.71B
Average +0.18%+0.63%+44.20%+174.79% 25.24B
Weighted average by Cap. -0.11%+0.94%+40.74%+139.34%

Financials

2026 *2027 *
Net sales 2.17B 2.47B 2.02B 1.85B 3.48B 236B 3.53B 23.99B 9.37B 117B 9.26B 9.06B 404B 2.23B 2.54B 2.08B 1.91B 3.58B 243B 3.63B 24.68B 9.64B 120B 9.53B 9.32B 415B
Net income -1.04B -1.19B -970M -891M -1.67B -114B -1.7B -11.53B -4.5B -56.14B -4.45B -4.35B -194B -1.16B -1.32B -1.08B -996M -1.87B -127B -1.89B -12.89B -5.03B -62.73B -4.97B -4.87B -217B
Net Debt -10.85B -12.35B -10.1B -9.28B -17.42B -1,184B -17.65B -120B -46.91B -585B -46.35B -45.35B -2,021B -9.29B -10.56B -8.64B -7.94B -14.91B -1,013B -15.1B -103B -40.13B -500B -39.65B -38.8B -1,729B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
27/07/26 USD 91.09 +1.97% 687,342
24/07/26 USD 89.33 -2.97% 886,104
23/07/26 USD 92.06 +0.25% 539,216
22/07/26 USD 91.83 -0.54% 508,360
21/07/26 USD 92.33 +0.18% 696,991
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
80.08EUR
Average target price
106.88EUR
Spread / Average Target
+33.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock